Basic information
- Standard SMILES
O=C1CCCCCO1- InChIKey
PAPBSGBWRJIAAV-UHFFFAOYSA-N- Molecular formula
- C6H10O2
- Average molar mass
- 114.14 g/mol
- Monoisotopic mass
- 114.06807956
Overview
Hexano-6-lactone is a -lactone that is oxepane substituted by an oxo group at position 2.
Names & identifiers
- Preferred name
- epsilon-CAPROLACTONE
- IUPAC
- oxepan-2-one
- English name
- ε-Caprolactone
- Molecular formula
- C6H10O2
- Molecular weight
- 114.14
Names & synonyms
Show more names
Database identifiers
- CAS
502-44-3- PubChem CID
- 10401
- DTXSID
DTXSID4027159- ChEMBL
CHEMBL373123- ChEBI
CHEBI:17915- UNII
- 56RE988L1R
- EC Number
- 207-938-1
- Nikkaji
- J1.566K
Properties
Computed structural properties
- XLogP
- 0
- Topological polar surface area
- 26.3 Ų
- Hydrogen bond donors
- 0
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 0
- Heavy atoms
- 8
- Formal charge
- 0
- Complexity
- 88.5
Experimental & physicochemical properties
LogP
log Kow= 1.215 (calc)
0.68
Density
1.07 g/cm³
Relative density of the vapour/air-mixture at 20 °C (air = 1): 1.00
1.0761 @ 20°C
Boiling Point
237 °C
215 °C @760 [mm Hg]
Melting Point
-1.5 °C
-1 °C
Vapor Pressure
0.13 [mmHg]
1.35X10-1 mm Hg at 25 °C
Vapor pressure, Pa at 25 °C: 0.8
0.01 [mm Hg] @20 °C
Physical Description
CBI; Liquid
Colorless liquid; Miscible in water; [eChemPortal: SIDSUNEP] Colorless liquid; [MSDSonline]
COLOURLESS HYGROSCOPIC LIQUID WITH CHARACTERISTIC ODOUR.
Physicochemical properties
- Melting point
- -1 °C · -1 °C
- Boiling point
- 96 · 96-97.5 °C10 mm Hg(lit.)
- Density
- 1.03 g/mL · 1.03 g/mL at 25 °C(lit.)
- vapor density
- 3.9 · 3.9 (vs air)
- vapor pressure
- 0.01 mm · 0.01 mm Hg ( 20 °C)
- refractive index
- 20 · n20/D 1.463(lit.)
- Flash point
- 229 °F · 229 °F
- storage temp.
- 30 °C · Store below +30°C.
- solubility
- Chloroform, Ethyl Acetate
- form
- Liquid
- color
- Clear colorless, yellowing on aging
- explosive limit
- 1.2 · 1.2-9%(V)
- Water Solubility
- 1000 MG/L · >1000 MG/L (20 ºC)
- BRN
- 106919 · 106919
- Henry's Law Constant
- 5.5 · 5.5×10-2 mol/(m3Pa) at 25℃, HSDB (2015)
- InChI
- 1S/C6H10O2/c7-6-4-2-1-3-5-8-6/h1-5H2
- InChIKey
- PAPBSGBWRJIAAV-UHFFFAOYSA-N
- SMILES
- O=C1CCCCCO1
- LogP
- 0.32 at · 0.32 at 20℃
- CAS DataBase Reference
- 502 · 502-44-3(CAS DataBase Reference)
- EWG's Food Scores
- 1 · 1
- FDA UNII
- 56 RE988L1R · 56RE988L1R
- NIST Chemistry Reference
- 2 · 2-Oxepanone(502-44-3)
- EPA Substance Registry System
- 2 · 2-Oxepanone (502-44-3)
- UNSPSC Code
- 12352115 · 12352115
- NACRES
- 23 · NA.23
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 319 · H319
- Precautionary statements
- 264 · P264-P280-P305+P351+P338-P337+P313
- PPE
- Eyeshields, Gloves, type ABEK (EN14387) respirator filter
- Hazard Codes
- Xi
- Risk Statements
- 37 · 37/38-41-36/38
- Safety Statements
- 26 · 26-39-37/39
- WGK Germany
- 2 · 2
- RTECS
- 8400000 · MO8400000
- Autoignition Temperature
- 204 °C · 204 °C
- TSCA
- TSCA listed
- HS Code
- 29322090 · 29322090
- Storage Class
- 10 · 10 - Combustible liquids
- Hazard Classifications
- 2 · Eye Irrit. 2
- Hazardous Substances Data
- 502 · 502-44-3(Hazardous Substances Data)
- Toxicity
- 50 orally · LD50 orally in Rabbit: > 2000 mg/kg LD50 dermal Rabbit 5990 mg/kg
- REACH Registrations
- Active
Safety & regulation
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 34.5% (266 of 770) of reports.
Warning
H319 (60.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)
Aggregated GHS information provided per 770 reports by companies from 8 notifications to the ECHA C&L Inventory.
Hazard information
Regulatory Information
Chemical: 2-Oxepanone
Council Directive (EEC) No 109/1989 (Repealed by Reg. EC No 1935/2004 (amended))
2-Oxepanone is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 2-Oxepanone are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Status: Active Update: 07-04-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/14740
Caprolactone: Does not have an individual approval but may be used under an appropriate group standard
Hazards Summary
Emergency treatment: irritants; [HSDB] Rapidly hydrolyzed in the body to 6-hydroxyhexanoic acid and rapidly excreted in urine; Irritating to eyes; No adverse effects in a 9-day inhalation study at 45 ppm; No evidence of reproductive effects; [ToxPlanet: UNEP: SIDS] An irritant; [MSDSonline]
Safety & protection
First Aid Measures
Fresh air, rest.
Rinse skin with plenty of water or shower.
Rinse with plenty of water (remove contact lenses if easily possible). Refer for medical attention.
Rinse mouth.
Protective Action Criteria (PAC)
13 [mg/m3]
140 [mg/m3]
850 [mg/m3]
Toxicology
Environmental Fate
TERRESTRIAL FATE: There are no biodegradation studies in soil to indicate whether biodegradation of caprolactone may be significant. An estimated Koc value of 109.1(1) suggests high mobility in soil(2,SRC).
AQUATIC FATE: Volatilization half-lives for caprolactone of 0.35 and 3.9 days have been estimated for a model river (one meter deep) and a model environmental pond, respectively(1-2). An estimated Koc of 109.1 and BCF of 4.94 for caprolactone indicate that adsorption to sediment and bioconcentration in aquatic organisms are not important fate processes(1). No information on biodegradation of caprolactone was available(SRC).
ATMOSPHERIC FATE: Based on a measured vapor pressure of 1.35X10-1 mm Hg at 25 °C(1), caprolactone can be expected to exist almost entirely in the vapor-phase in the ambient atmosphere(SRC). Vapor-phase caprolactone is degraded slowly in the ambient atmosphere by reaction with photochemically formed hydroxyl radicals; the half-life for this reaction in air can be estimated to be about 2.76 days(2,SRC).
Human Toxicity Excerpts
The efficacy, safety and patient acceptance of a subcutaneous implant of levonorgestrel contained in a biodegradable capsule of poly (E-caprolactone) wax are reported in 48 women, aged 18-40 yr, 32 of whom were given an implant containing a 21.6 mg dose of levonorgestrel, and 16 were initially given an implant containing 12 mg of levonorgestrel; patients were followed up for one yr. Ovulation occurred in all cycles in patients given the 12 mg dose, and in 26.3% of cycles in the group given 21.6 mg. Levonorgestrel blood levels were significantly lower in those given 12 mg. All patients initially given 12 mg were given a second implant of the same dose. Bleeding patterns were regular in most women who ovulated and irregular in most remaining subjects. It was assumed that changes in cervical mucus and the endometrium contributed to effective contraception despite the frequency of ovulation.
Environmental Bioconcentration
Based on a calculated log Kow of 1.215(1), the BCF for caprolactone can be estimated to be 4.94 using a recommended regression derived equation(2,SRC). This BCF value indicates that bioconcentration of caprolactone in aquatic organisms is not significant(SRC).
Volatilization from Water/Soil
The Henry's Law constant for caprolactone can be estimated to be 1.809X10-4 atm-cu m/mole at 25 °C(1,SRC). Using this value of Henry's Law constant, one estimates that the volatilization half-life of caprolactone from a model river 1 m deep flowing 1 m/sec with a wind velocity of 3 m/sec has been estimated to be approximately 0.35 days(2,SRC). The volatilization half-life of caprolactone from a model environmental pond can be estimated to be approximately 3.9 days(3,SRC).
Non-Human Toxicity Excerpts
THE MUTAGENIC ACTIVITES OF 79 CARCINOGENS, NONCARCINOGENS, & STRUCTURALLY RELATED CMPD TOWARD SALMONELLA TYPHIMURIUM & SACCHAROMYCES CEREVISIAE D3 STRAINS WERE INVESTIGATED IN THE IP HOST-MEDIATED ASSAY. EPSILON-CAPROLACTONE WAS NOT MUTAGENIC TOWARD SALMONELLA TYPHIMURIUM STRAINS TA1530 OR TA1535 IN THE HOST-MEDIATED ASSAY, AND DID NOT INCREASE MITOTIC RECOMBINATION IN SACCHAROMYCES CEREVISIAE D3.
OF 13 DIRECT-ACTING ALKYLATING AGENTS, ONLY ONE NONCARCINOGEN, EPSILON-CAPROLACTONE, WAS TESTED IN THE SYRIAN HAMSTER EMBRYO CELL TRANSFORMATION SYSTEM, & IT YIELDED NEGATIVE RESULTS IN BOTH IN VITRO SYSTEMS.
Environmental Abiotic Degradation
The rate constant for the vapor-phase reaction of caprolactone with photochemically produced hydroxyl radicals has been estimated to be 5.81X10-12 cu cm/molecule-sec at 25 °C(1) which corresponds to an atmospheric half-life of about 2.76 days at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1,SRC).
Environmental Fate/Exposure Summary
Caprolactone may be released to the environment during its use as an intermediate in the manufacture of caprolactam, adhesives, urethane coatings and elastomers, solvents, synthetic fibers, as a diluent for epoxy resins, during organic synthesis, and as a reaction product of peracetic acid and cyclohexanone. If released to the atmosphere, caprolactone is degraded slowly by reaction with photochemically produced hydroxyl radicals (estimated half-life of 2.76 days in air). A calculated Koc value of 109.1 suggests a high mobility of caprolactone in soil. A calculated BCF of 4.94 for caprolactone indicates that its bioconcentration in aquatic organisms should not be important. Based on a calculated Henry's Law constant of 1.809X10-4 atm cu-m/mole at 25 °C, and half-lives of 3.9 and 0.35 days from a model environmental pond and a model river, respectively, caprolactone is expected to volatilize rapidly from water. In occupational settings, exposure to caprolactone may occur through inhalation of vapors and through eye and skin contact. (SRC)
Safety data
- PPE
- Eyeshields, Gloves, type ABEK (EN14387) respirator filter
- wgk
- 2
- tsca
- TSCA listed
- rtecs
- MO8400000
- hs_code
- 29322090
- Toxicity
- LD50 orally in Rabbit: > 2000 mg/kg LD50 dermal Rabbit 5990 mg/kg
- risk_code
- 37/38-41-36/38
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- hazard_code
- Xi
- safety_code
- 26-39-37/39
- Storage Class
- 10 - Combustible liquids
- Hazard statements
- H319
- REACH Registrations
- Active
- Hazard Classifications
- Eye Irrit. 2
- Autoignition Temperature
- 204 °C
- Precautionary statements
- P264-P280-P305+P351+P338-P337+P313
- Hazardous Substances Data
- 502-44-3(Hazardous Substances Data)
Chemistry & industry
Pharmacology
Uses & manufacturing
Uses
Used as a solvent, a diluent for epoxy resins, and an intermediate in adhesives, urethane coatings, and elastomers; [Hawley] Used in the production of polymers (polycaprolactones); [eChemPortal: SIDSUNEP]
Plastic Composites Manufacturing [Category: Industry]
INTERMEDIATE IN ADHESIVES, URETHANE COATINGS & ELASTOMERS; SOLVENT; DILUENT FOR EPOXY RESINS; SYNTHETIC FIBERS; IN ORG SYNTHESIS
General Manufacturing Information
Paint and Coating Manufacturing
2-Oxepanone: ACTIVE
Applications
UsesIntermediate in adhesives, urethane coatings, and elastomers; solvent; diluent for epoxy resins; synthetic fibers; organic synthesis.
Usesε-Caprolactone is widely used as a monomer in the manufacturing of highly specialized polymers. It is mainly utilized as a precursor to caprolactam. It finds an application in the synthesis of polyglecaprone, which is used as a suture material in surgery.
Usesε-caprolactone is popularly used in the preparation of poly caprolactone (PCL).
General Descriptionε-caprolactone is a cyclic ester. Ring opening polymerization of ε-caprolactone initiated by, tributylin n butoxide, ethyl magnesium bromide, or samarium acetate or heteropolyacid, leads to the formation of poly caprolactone (PCL).
Upstream & downstream products
Upstream raw materials
Downstream products
Additional notes
DefinitionChEBI: A epsilon-lactone that is oxepane substituted by an oxo group at position 2.
Related reactions
Linked notes
Loading…